MAPT and Alzheimer disease: Considering the pro-aggregation properties of N368-Tau fragments in vitro reported by others [29] and confirmed by our work (Fig. 2), we hypothesized that such fragments may drive the aggregation of Tau in AD and preferentially accumulate into insoluble Tau inclusions.